𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An evaluation of the Factor V Leiden mutation in a cohort of African-American pregnant women

✍ Scribed by Nancy C. Rose; Y. Lynn Wang; A. George Neubert; Nancy W. Roth; Mengrong Li; Robert B. Wilson


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
32 KB
Volume
18
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

✦ Synopsis


The objective of this work was to study the prevalence of the Factor V Leiden mutation in an obstetrical clinic largely comprised of African-American women. A cross-sectional study was performed evaluating a total of 231 consecutive women of African-American origin. Of these patients, 21 were considered at high risk for thrombosis, but none was found to carry the mutation. One patient (0β€’4 per cent) of the total was heterozygous for the Factor V Leiden mutation. African-American women do not appear to be at an increased risk of being heterozygous or homozygous for the Leiden mutation. This low prevalence may be confounded by ascertainment bias in a population of pregnant women. 1998 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Prevalence of the factor V-Leiden mutati
✍ Gregg, Jeff P.; Yamane, Akemi J.; Grody, Wayne W. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 8 KB πŸ‘ 2 views

Resistance to activated protein C (APC) is the most common risk factor for venous thromboembolism, a major cause of morbidity and mortality with an incidence of about 1/1,000 per year. The Arg 506 to Gln mutation in exon 10 of the coagulation factor V gene (factor V-Leiden) has been found to be resp

A deletion-insertion mutation in the pho
✍ Tayebi, Nahid ;Andrews, David Q. ;Park, Joseph K. ;Orvisky, Eduard ;McReynolds, πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

## Abstract Congenital disorders of glycosylation (CDG) are a group of metabolic disorders with multisystemic involvement characterized by abnormalities in the synthesis of N‐linked oligosaccharides. The most common form, CDG‐Ia, resulting from mutations in the gene encoding the enzyme phosphomanno